NCT03581292 2026-04-13Veliparib, Radiation Therapy, and Temozolomide in Treating Patients With Newly Diagnosed Malignant Glioma Without H3 K27M or BRAFV600 MutationsNational Cancer Institute (NCI)Phase 2 Active not recruiting38 enrolled 13 charts